Medicare PBM Restrictions Would Lead To Higher Premiums, CBO Says

The PBM "transparency" provision in the Senate's Medicare prescription drug bill would lead to higher monthly premiums and higher beneficiary cost-sharing, the Congressional Budget Office said

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet